Integra LifeSciences Holdings Corporation (IART)

IART Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,300	3,405	4,683	5,674	5,471	5,004
Market Cap Growth	-40.84%	-27.30%	-17.47%	3.71%	9.33%	30.26%
Enterprise Value	3,679	4,777	5,842	6,812	6,656	6,263
PE Ratio	58.38	50.26	25.94	33.56	40.86	99.68
PS Ratio	1.50	2.21	3.01	3.68	3.99	3.30
PB Ratio	1.44	2.14	2.60	3.37	3.61	3.53
P/FCF Ratio	37.75	46.58	20.07	21.46	32.45	30.90
P/OCF Ratio	17.75	24.33	17.71	18.16	26.84	21.62
EV/Sales Ratio	2.41	3.10	3.75	4.42	4.85	4.13
EV/EBITDA Ratio	16.50	18.51	15.19	17.52	23.43	27.40
EV/EBIT Ratio	37.18	36.07	22.17	25.70	40.32	54.91
EV/FCF Ratio	60.39	65.36	25.04	25.76	39.48	38.68
Debt / Equity Ratio	1.28	1.06	0.90	0.98	1.09	1.03
Debt / EBITDA Ratio	9.16	6.51	4.20	4.25	5.83	6.38
Debt / FCF Ratio	33.52	23.01	6.92	6.25	9.82	9.00
Quick Ratio	2.99	1.85	2.24	2.19	1.73	1.43
Current Ratio	4.68	3.45	3.62	3.39	3.09	2.59
Asset Turnover	0.40	0.41	0.41	0.41	0.40	0.46
Interest Coverage	1.87	2.58	5.31	5.26	2.31	2.11
Return on Equity (ROE)	2.50%	4.20%	10.60%	10.50%	9.60%	3.60%
Return on Assets (ROA)	1.00%	1.80%	4.80%	4.50%	3.90%	1.50%
Return on Capital (ROIC)	1.90%	2.85%	5.90%	4.66%	6.84%	2.72%
Earnings Yield	1.75%	1.99%	3.86%	2.98%	2.45%	1.00%
FCF Yield	2.65%	2.15%	4.98%	4.66%	3.08%	3.24%
Buyback Yield / Dilution	5.57%	3.81%	2.30%	-0.30%	1.46%	-2.97%
Total Shareholder Return	5.57%	3.81%	2.30%	-0.30%	1.46%	-2.97%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).